Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.52K Sell
48
-6
-11% -$317 ﹤0.01% 181
2026
Q1
$2.98K Buy
54
+6
+13% +$325 ﹤0.01% 169
2025
Q4
$2.35K Buy
+48
New +$2.24K ﹤0.01% 177

Other funds holding GSK

Nvest Wealth Strategies's GSK Position: Q2 2026 in Review

Nvest Wealth Strategies reduced its GSK (GSK) stake by 11% in Q2 2026, selling an estimated $317 and leaving 48 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #181.

Nvest Wealth Strategies first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.98K in Q1 2026. 627 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Nvest Wealth Strategies held 48 shares of GSK worth $2.52K as of Q2 2026.
  • Nvest Wealth Strategies sold 6 GSK shares in Q2 2026, an estimated $317.
  • GSK made up ﹤0.01% of Nvest Wealth Strategies's portfolio in Q2 2026, its #181 holding.
  • Nvest Wealth Strategies first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Nvest Wealth Strategies's GSK position peaked at $2.98K in Q1 2026.
  • 627 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Nvest Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.